Related references
Note: Only part of the references are listed.Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial
Katsumi Hirose et al.
RADIOTHERAPY AND ONCOLOGY (2021)
HIF-1α affects sensitivity of murine squamous cell carcinoma to boron neutron capture therapy with BPA
Yu Sanada et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2021)
Enhancement of Cancer Cell-Killing Effects of Boron Neutron Capture Therapy by Manipulating the Expression of L-Type Amino Acid Transporter 1
Ken Ohnishi et al.
RADIATION RESEARCH (2021)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)
Junichi Hiratsuka et al.
JOURNAL OF RADIATION RESEARCH (2020)
Disruption of Hif-1α enhances cytotoxic effects of metformin in murine squamous cell carcinoma
Yu Sanada et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2018)
Development and Elucidation of a Novel Fluorescent Boron-Sensor for the Analysis of Boronic Acid-Containing Compounds
Yoshihide Hattori et al.
SENSORS (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes
Van Trung Chu et al.
BMC BIOTECHNOLOGY (2016)
Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy
Tsubasa Watanabe et al.
BMC CANCER (2016)
L-phenylalanine preloading reduces the 10B(n, α)7Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours
Tsubasa Watanabe et al.
CANCER LETTERS (2016)
Visualization of Boronic Acid Containing Pharmaceuticals in Live Tumor Cells Using a Fluorescent Boronic Acid Sensor
Yoshihide Hattori et al.
ACS SENSORS (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2
Printip Wongthai et al.
CANCER SCIENCE (2015)
Detection of boronic acid derivatives in cells using a fluorescent sensor
Yoshihide Hattori et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009
Keisha A. Houston et al.
LUNG CANCER (2014)
FBPA PET in boron neutron capture therapy for cancer: prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model
Kohei Hanaoka et al.
EJNMMI RESEARCH (2014)
Predominant contribution of L-type amino acid transporter to 4-borono-2-18F-fluoro-phenylalanine uptake in human glioblastoma cells
Mitsuyoshi Yoshimoto et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
Rolf F. Barth et al.
RADIATION ONCOLOGY (2012)
BPA uptake does not correlate with LAT1 and Ki67 expressions in tumor samples (results of EORTC trial 11001)
Andrea Wittig et al.
APPLIED RADIATION AND ISOTOPES (2011)
L-Amino Acid Transporter-1 and Boronophenylalanine-Based Boron Neutron Capture Therapy of Human Brain Tumors
Allah Detta et al.
CANCER RESEARCH (2009)
Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma
Shinji Kawabata et al.
JOURNAL OF RADIATION RESEARCH (2009)
Boron neutron capture therapy of cancer: Current status and future prospects
RF Barth et al.
CLINICAL CANCER RESEARCH (2005)
Share Paper
